Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 9Neoplasms 4Breast Neoplasms 3Weight Loss 2Ventricular Dysfunction, Left 1Urinary Incontinence 1Sexual Dysfunction, Physiological 1Sarcoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Melanoma 1Lymphoma 1Leukemia 1Insulin Resistance 1Hypoxia 1Hematologic Neoplasms 1Heart Failure 1Head and Neck Neoplasms 1Fecal Incontinence 1Fatigue 1Cardiotoxicity 1Carcinoma, Renal Cell 1Cachexia 1Brenner Tumor 1Breast Diseases 1Brain Neoplasms 1Bone Metastases 1Body Weight 1

Interventions

Megestrol Acetate 2Resistance Training 1Mirtazapine 1Metformin 1Exercise 1Diet Therapy 1Caseins 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Body Weight × Exercise × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡